Evidence map›Paper›PMID 41448834›Full record

ArticleJournal for immunotherapy of cancer2025

Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort study.

Chiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, Sarah Morin, Anne-Claire Mamez, Federica Giannotti, Yara H Younes, Sisi Wang, Pragallabh Purwar, Constant Tellinga and 4 more

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal for immunotherapy of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chiara BernardiDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland chiara.bernardi@hug.ch federico.simonetta@unige.ch.
Amandine PradierDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Stavroula Masouridi-LevratDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Sarah MorinDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Anne-Claire MamezDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Federica GiannottiDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Yara H YounesDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Sisi WangDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Pragallabh PurwarTranslational Research Center for Oncohematology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Constant TellingaDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0009-0005-5248-1840
Jean VillardDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Yves ChalandonDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland.
Christoph ScheiermannTranslational Research Center for Oncohematology, Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Federico SimonettaDivision of Hematology, Geneva University Hospitals, Geneva, Switzerland chiara.bernardi@hug.ch federico.simonetta@unige.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological clock plays a central role in hematopoiesis and immune regulation, making circadian rhythms an increasingly important factor in immunotherapies and cellular therapies such as allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous work by Hou

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdolescentAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTime FactorsTransplantation, HomologousTreatment OutcomeYoung AdultGraft versus host disease - GVHDHematologic MalignanciesInfusionTransplant

Identifiers

PMID41448834
PMCPMC12742167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.